FEATURED SLIDESHOW
Who Is The Worst CEO?Mad Money needed new inductees for its
Wall of Shame, so we asked viewers for
nominations.
RECENT POSTS
- Cramer: Buy These 2 Dividend Plays
- Remorseful Regulator Leads Reform Fight
- Lightning Round: AT&T, Verizon, Novartis and More
- Lightning Round OT: Alcoa, Weight Watchers and More
- Why Amazon Rules Retail
- Nordic American: Sinking Ship or Titan Tanker?
- Cramer: What Monday’s Housing Number Really Means
- Cramer: Buy These Banks, If...
- Time to Buy Treasurys?
- Lightning Round: Las Vegas Sands, ADC Telecom, Satyam Computer and More
MAD MONEY FEATURES
PODCASTSWatch the Lightning Round whenever and wherever you want.
OFFICIAL MAD MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
CRAMERS SOUNDBOARDAdmit it: You've always wanted to hit the "They
know nothing!" button. Here’s your chance.
CHECK OUT OUR PHOTOSCheck out Cramer on set, back to school, behind the scenes and more.
SHOP FOR MAD MERCHANDISEBuy Cramer books, bobbleheads and other Mad Money merchandise.
RING TONESPick up the phone! It's Cramer! New Mad Money sounds for your cell phone.
TEXT MESSAGE ALERTMad Money's mobile. Get show highlights sent to your phone.
Text Size 
The Dow trended down on Tuesday, Cramer told viewers, because all the wrong stocks went up.
Not that a loss of just 16 points is a big deal. But the action in certain stocks took the steam out of the rally we’ve enjoyed since early March. This trend needs to reverse, Cramer said, if we are to continue our move higher.
So what happened? Wall Street favored food and drug stocks today. Kraft [KFT
Loading...
()
] reported strong earnings, and that set in motion a buying spree in Molson Coors [TAP
Loading...
()
] – another earnings winner – Heinz [HNZ
Loading...
()
] and Campbell [CPB
Loading...
()
]. The pharma firms followed closely behind, as Eli Lilly [LLY
Loading...
()
], Johnson & Johnson [JNJ
Loading...
()
], Bristol-Myers Squibb [BMY
Loading...
()
], Pfizer [PFE
Loading...
()
] and Abbott Labs [ABT
Loading...
()
] all rallied. So, too, did Celgene [CELG
Loading...
()
].
The problem is that the money generated from the massive selling of these stocks that we’ve seen for the past eight weeks had been pouring into oil, tech and the banks. These were the rally leaders upon which the market depended for the big move. Without cash flowing steadily into these names, the momentum petered out. Poor earnings from Chesapeake Energy [CHK
Loading...
()
] didn’t help, either. Nor did Morgan Stanley’s downgrade of Anadarko Petroleum [APC
Loading...
()
] and Devon Energy [DVN
Loading...
()
]. These two events killed an under-the-radar move by natural gas stocks that had been one part of the overall rally.
But it wasn’t all bad today. Research in Motion [RIMM
Loading...
()
] was up on increased earnings estimates, and Apple [AAPL
Loading...
()
] is still going strong. As are Amazon [AMZN
Loading...
()
] and Google [GOOG
Loading...
()
]. And late-day rallies in the coppers and the coals pushed us to a higher close than we otherwise would have had. Also, Disney [DIS
Loading...
()
] reported a great quarter after the bell, so that bodes well for Wednesday’s open.
The bottom line, though, is that we need selling to return to the food and drug stocks in order for this rally to resume, Cramer said. Without broad-based support from retail investors, hedge funds and mutual funds, the upside won’t happen any other way.
Cramer's charitable trust owns Abbott Labs and Celgene.
Call Cramer: 1-800-743-CBNC
Questions for Cramer?
Questions, comments, suggestions for the Mad Money website?
Data is a real-time snapshot *Data is delayed at least 15 minutes